2024-10-22 20:39:45
CStone announced the global multi-regional registration trial of anti-PD-1 antibody nofazinlimab in combination with lenvatinib as first-line treatment for patients with advanced hepatocellular carcinoma successfully reached the prespecified enrollment ta
Corporate/ 2023-07-24
CStone announced the global multi-region...

SUZHOU,China,March 18,2022--CStone Pharmaceuticals ("CStone",HKEX: 2616),a leading biopharmaceutical company focused on research,d...

Lynk Pharmaceuticals and Simcere announced Strategic Commercialization Partnership upon novel JAK1 inhibitor LNK01001
Health/ 2023-07-22
Lynk Pharmaceuticals and Simcere announc...

HANGZHOU,China,March 18,2022-- On March 18,2022,Lynk Pharmaceuticals Co.,Ltd. (Lynk Pharmaceuticals) and Simcere (2096.HK) announced a strat...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release